Get the Stockscreener App
12.88
2.14%
0.27
After Hours:
12.83
-0.05
-0.39%
Daxor Corporation stock is traded at $12.88, with a volume of 1,654.
It is up +2.14% in the last 24 hours and up +10.46% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$12.61
Open:
$12.8116
24h Volume:
1,654
Relative Volume:
0.06
Market Cap:
$62.30M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
42.89
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
-6.73%
1M Performance:
+10.46%
6M Performance:
+60.06%
1Y Performance:
+48.56%
1-Day Range:
$12.81
$12.88
1-Week Range:
$12.52
$13.91
52-Week Range:
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
12.88 | 62.85M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Can Daxor Corporation stock sustain free cash flow growthJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Using data filters to optimize entry into Daxor CorporationJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Using fundamentals and technicals on Daxor Corporation2025 Trading Recap & Technical Entry and Exit Alerts - newser.com
Chart overlay techniques for tracking Daxor CorporationMarket Movement Recap & AI Enhanced Trading Signals - newser.com
Is Daxor Corporation stock a buy before product launchesQuarterly Investment Review & Entry and Exit Point Strategies - newser.com
Will Daxor Corporation stock maintain dividend yieldJuly 2025 Patterns & Capital Efficiency Focused Ideas - newser.com
What earnings revisions data tells us about Daxor CorporationPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Can Daxor Corporation (DX5) stock retain market dominanceJuly 2025 Movers & Community Verified Swing Trade Signals - newser.com
Momentum divergence signals in Daxor Corporation chart2025 Market Overview & Risk Managed Trade Strategies - newser.com
Why Daxor Corporation (DX5) stock could rally stronglyPortfolio Profit Report & Long-Term Growth Plans - newser.com
Will Daxor Corporation stock rally after Fed decisionsJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
Daxor (NASDAQ:DXR) Given Hold (C-) Rating at Weiss Ratings - MarketBeat
What technical patterns form on Daxor Corporation (DX5) stock chartsRecession Risk & AI Forecast Swing Trade Picks - newser.com
Can momentum traders help lift Daxor CorporationPortfolio Update Report & AI Enhanced Execution Alerts - newser.com
Daxor (NYSEAMERICAN:DXR) Stock Price Passes Above Fifty Day Moving AverageHere's Why - MarketBeat
Can Daxor Corporation recover in the next quarterEntry Point & Long-Term Capital Growth Strategies - newser.com
Is Daxor Corporation meeting your algorithmic filter criteriaDollar Strength & Long-Term Capital Growth Strategies - newser.com
Daxor Corporation (NASDAQ:DXR) Short Interest Down 34.7% in September - MarketBeat
Maxim Group Maintains Daxor(DXR.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛
How to manage a losing position in Daxor CorporationWeekly Trade Report & Weekly Sector Rotation Insights - newser.com
Blood Volume, Reimagined: Daxor’s BVA Could Slash Testing Time and Save Lives - insights.citeline.com
Historical volatility pattern of Daxor Corporation visualizedQuarterly Market Review & Smart Allocation Stock Tips - newser.com
Technical analysis overview for Daxor Corporation stock2025 Biggest Moves & Weekly Momentum Stock Picks - newser.com
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA - GlobeNewswire
Daxor Corporation's BVA Technology Proven to Reduce Hospital Readmissions and Enhance Survival Rates in Heart Failure Patients - Quiver Quantitative
Zero Hospital Readmissions: Daxor's New Blood Volume Tech Shows Perfect Results in Heart Failure Study - Stock Titan
Daxor (NASDAQ:DXR) Trading 7.6% Higher – What’s Next? - Defense World
Comparing Daxor (NASDAQ:DXR) & LifeStance Health Group (NASDAQ:LFST) - Defense World
Can Oswal Agro Mills Limited Deliver Growth Even in a Bearish MarketMarket Sentiment Shifts & Low Risk Trading Alerts - earlytimes.in
What drives Daxor Corporation stock priceTechnology Stock Trends & Follow Top Performers in the Community - earlytimes.in
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Daxor Corporation Stock (DXR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Michel Robert J | Chief Financial Officer |
Mar 10 '25 |
Buy |
8.00 |
1,000 |
8,000 |
17,050 |
| Feldschuh Michael Richard | Chief Executive Officer |
Mar 10 '25 |
Buy |
7.68 |
3,360 |
25,805 |
210,852 |
2.84%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):